LingJ, KorenG. Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy. Expert Rev Vaccines, 2016; 15:239–256.
2.
NguyenGC, SeowCH, MaxwellC, et al.The Toronto consensus statements for the management of IBD in pregnancy. Gastroenterology, 2016; 150:734–757.
3.
McConnellRA, MahadevanU. Use of immunomodulators and biologics before, during, and after pregnancy. Inflamm Bowel Dis, 2016; 22:213–223.
4.
MahadevanU, McConnellRA, ChambersC. Drug safety and risk of adverse outcomes for pregnant patients with inflammatory bowel diseases. Gastroenterology, 2016; PMID: 27769809; DOI: 10.1053/j.gastro.2016.10.013.
5.
de LimaA, ZelinkovaZ, van der EntC, et al.Tailored anti-TNF therapy during pregnancy in patients with IBD: Maternal and fetal safety. Gut, 2016; 65:1261–1268.
MorrisR, MatthesJ. Serotonin syndrome in a breast-fed neonate. BMJ Case Rep, 2015; PMID: 25948853; DOI: 10.1136/bcr-2015-209418.
8.
LeslieKK, KoilC, RayburnWF. Chemotherapeutic drugs in pregnancy. Obstet Gynecol Clin North Am, 2005; 32:627–640.
9.
Moses-KolkoEL, BogenD, PerelJ, et al.Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: Literature review and implications for clinical applications. JAMA, 2005; 293:2372–2383.
10.
Eslami-ShahrbabakiM, BarfehD, Eslami-ShahrbabakiP. Breastfeeding: Neglect or excessive support? A case report of child abuse by a negligent heroin-dependent mother. Addict Health, 2015; 7:92–95.
11.
KhanSJ, FershME, ErnstC, et al.Bipolar disorder in pregnancy and postpartum: Principles of management. Curr Psychiatry Rep, 2016; 18:13.
12.
TomsonT, BattinoD. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet, 2007; 46:209–219.
